Novozymes Total Long Term Liabilities 2011-2025 | NVZMY
Novozymes total long term liabilities from 2011 to 2025. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Novozymes total long term liabilities for the quarter ending March 31, 2025 were $2.799B, a 146.4% increase year-over-year.
- Novozymes total long term liabilities for 2024 were $3.172B, a 222.3% increase from 2023.
- Novozymes total long term liabilities for 2023 were $0.984B, a 2.33% increase from 2022.
- Novozymes total long term liabilities for 2022 were $0.962B, a 12.24% decline from 2021.
Novozymes Annual Total Long Term Liabilities
(Millions of US $) |
| 2024 |
$3,172 |
| 2023 |
$984 |
| 2022 |
$962 |
| 2021 |
$1,096 |
| 2020 |
$782 |
| 2019 |
$633 |
| 2018 |
$433 |
| 2017 |
$384 |
| 2016 |
$498 |
| 2015 |
$431 |
| 2014 |
$571 |
| 2013 |
$497 |
| 2012 |
$505 |
| 2011 |
$498 |
| 2010 |
$402 |
Novozymes Quarterly Total Long Term Liabilities
(Millions of US $) |
| 2025-03-31 |
$2,799 |
| 2023-12-31 |
$984 |
| 2023-09-30 |
$1,084 |
| 2023-06-30 |
$1,109 |
| 2023-03-31 |
$1,136 |
| 2022-12-31 |
$962 |
| 2022-09-30 |
$905 |
| 2022-06-30 |
$978 |
| 2022-03-31 |
$1,004 |
| 2021-12-31 |
$1,096 |
| 2021-09-30 |
$925 |
| 2021-06-30 |
$936 |
| 2021-03-31 |
$949 |
| 2020-12-31 |
$782 |
| 2020-09-30 |
$790 |
| 2020-06-30 |
$752 |
| 2020-03-31 |
$733 |
| 2019-12-31 |
$633 |
| 2019-09-30 |
$543 |
| 2019-06-30 |
$555 |
| 2019-03-31 |
$594 |
| 2018-12-31 |
$433 |
| 2018-09-30 |
$456 |
| 2018-06-30 |
$503 |
| 2018-03-31 |
$539 |
| 2017-12-31 |
$384 |
| 2017-09-30 |
$489 |
| 2017-06-30 |
$480 |
| 2017-03-31 |
$489 |
| 2016-12-31 |
$498 |
| 2016-09-30 |
$515 |
| 2016-06-30 |
$507 |
| 2016-03-31 |
$429 |
| 2015-12-31 |
$431 |
| 2015-09-30 |
$448 |
| 2015-06-30 |
$442 |
| 2015-03-31 |
$475 |
| 2014-12-31 |
$571 |
| 2014-09-30 |
$607 |
| 2014-06-30 |
$646 |
| 2014-03-31 |
$669 |
| 2013-12-31 |
$497 |
| 2013-09-30 |
$540 |
| 2013-06-30 |
$544 |
| 2013-03-31 |
$535 |
| 2012-12-31 |
$505 |
| 2012-09-30 |
$350 |
| 2012-06-30 |
$373 |
| 2012-03-31 |
$370 |
| 2011-12-31 |
$498 |
| 2011-09-30 |
$460 |
| 2011-06-30 |
$459 |
| 2011-03-31 |
$432 |
| 2010-12-31 |
$402 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Chemicals - Specialty |
$32.711B |
$4.149B |
|
Novozymes A/S is primarily engaged in the development, production, and distribution of enzymes. Its business consists of two segments, enzyme business and bio business. The Company's enzyme business segment offers detergent enzymes that are used in laundry and dishwashing, technical enzymes used in the transformation of starch into different kinds of sugars and have application in leather, textile, and forest product industries, food enzymes used in production of bread, wine, juice, beer, noodles, alcohol, and pasta and feed enzymes used in animal feed. Its bio business segment offers microorganisms that are used in industrial and municipal wastewater treatment, as well as in the cleaning of surfaces such as carpet, concrete, drain lines, and septic tanks in industrial and household applications. It also has application in the Biopharmaceutical ingredients used in pharmaceutical industry. Novozymes A/S is headquartered in Bagsvaerd, Denmark.
|
